Spanish Lenders BBVA, Sabadell Abandon Merger Talks

Spanish Lenders BBVA, Sabadell Abandon Merger Talks

Banco Bilbao Vizcaya Argentaria SA, Spain’s second-largest lender by assets, and smaller peer Banco de Sabadell SA ended their merger talks because of disagreements over pricing, underlining that consolidation in Europe’s fragmented banking system remains complicated. The banks disclosed the talks less than two weeks ago. BBVA said on Nov. 16 that it was conducting due […] More A quick overview of major market-moving events including economic reports and high-profile earnings scheduled for Nov 27 Sign in Sign in This October, U.S. housing sales hit their highest level since 2006. China’s residential real-estate investment was up 14% relative to the same month last year. Around the world, many housing markets have shrugged off a colossal economic slump, helped by low interest rates. In the short term, such investment is a boost to economic activity […] More

spanish-lenders-bbva,-sabadell-abandon-merger-talks

Banco Bilbao Vizcaya Argentaria SA, Spain’s second-largest lender by assets, and smaller peer Banco de Sabadell SA ended their merger talks because of disagreements over pricing, underlining that consolidation in Europe’s fragmented banking system remains complicated.

The banks disclosed the talks less than two weeks ago. BBVA said on Nov. 16 that it was conducting due diligence on Sabadell after agreeing to sell its operations in the U.S. to Pittsburgh-based PNC Financial Services Group Inc. for $11.6 billion.

Source: www.financialnewsherald.com

Author: Written by FinancialNews

facebook

tumblr

twitter


Today's Stock Market News & Events: 11/27/2020 - Schaeffer's Investment Research

Today’s Stock Market News & Events: 11/27/2020 – Schaeffer’s Investment Research

After Tuesday saw the Dow and S&P 500 close the session at record highs, stocks pulled back on Wednesday while traders processed the latest batch of unemployment data. Specifically, jobless claims came in at 778,000 on the week last week which was much higher than analysts’ predications. The Dow Jones Industrial Average (DJI – 29,872.47) shed 173.8 points, or 0.6% on the day on Wednesday. The S&P 500 Index (SPX – 3,629.65) fell 0.2%, for the day. The Nasdaq Composite (IXIC – 12,094.40) gained 0.5% for the day. The Cboe Volatility Index (VIX – 21.25) fell 1.8% for the day on Wednesday ahead of the Thanksgiving day off.

Today is a half day of trading for investors, still in observance of the Thanksgiving holiday yesterday. The markets will be open from 9:30 a.m. ET until 1:00 p.m. ET. There are no further earnings reports due out today and there will be no major economic data slated to be released during the half-day trading session today.

In case you missed here, here are some highlights from Wednesday’s jam-packed trading session:

  • How to Read Schaeffer’s Black Friday Indicator
  • Bull Notes Pour in for DELL Following Earnings, Revenue Beat
  • A Deep Dive into Carnival Stock After a 30-Day Rally
  • Can AMC Entertainment Stock Endure the Pandemic?
  • Hormel Foods Stock Signal Has Never Been Wrong
  • Resilient Clean Energy Stock Has Room to Run
  • Nordstrom Stock Surges on Slew of Post-Earnings Bull Notes
  • Canada Goose Stock Gets Cooked After Double Downgrade
  • Here is a Preview of What’s in Store for Traders Next Week

Looking ahead to next week, investors will get little chance to breathe following the holiday shortened week, as they’ll be immediately hit with a slew of data to digest as we enter peak holiday season with the beginning of December. Next week starts with home and motor vehicle data, as well as manufacturing reports. While Wednesday looks like a slow day, the Federal Reserve’s latest “Beige book” report is due out, as well as the ADP employment report. Thursday comes with the usual jobless claims data for investors to pore over. Next week will end with even more employment data is due out, in addition to trade deficit data and factory orders.

Source: www.schaeffersresearch.com

Author: Schaeffer’s Digital Content Team


Nuance Communications (NUAN) Stock Rose Over 26% In A Week After Q4 Results

Nuance Communications (NUAN) Stock Rose Over 26% In A Week After Q4 Results

Nuance Communications Inc. (NUAN) closed the Wednesday trading with a rise of 2.98 percent to conclude the session at $42.87. The provider of smart solutions has gained 26.31 percent over the week including a surge of 17 percent on last Thursday when price of its shares rose to $39.71 from a day earlier price of $33.94.

The business finished the fiscal year successfully with surpassing fourth-quarter revenue and earnings estimates and became the beneficiary of the healthcare sector shifting towards cloud platforms.

Revenue was 25 percent less than a year ago in the fourth quarter of fiscal year 2020 (ended September 30) and amounted to $352.9 million. Compared to $0.01 in Q4 2019, the GAAP loss was $0.08 per share. Operating cash flow increased to $79.3 million from continuing operations. The operating margin was 3.7%. The results surpassed Wall Street expectations. Against the backdrop of COVID-19, the fall in revenue was expected.

The growth of Nuance’s healthcare solutions division, which showed revenue growth of 29 percent to $386 million for the full year, was a positive indication. Sales growth of 38 percent year on year was demonstrated by Dragon Medical Cloud applications with speech recognition tools for healthcare professionals. At a time when more healthcare organization in the United States is moving to the cloud formats, Nuance expects more increases in revenue. In the direction of more effective natural language processing, the business is expanding its portfolio of medical solutions, developing AI applications that can perform conversation and provide situation analysis.

The management of Nuance assumes that the company will be able to demonstrate good organic growth in the next few quarters, which has not been seen for several years.

Nuance Communications Inc. (NUAN) stock is up 87.37 percent over the past six month while the gain rises to more than 140 percent since start of the year.

A $3 Stock to Change Your Life: Find Out How

You can see why the world’s most famed tech companies are all signing blockbuster deals with this little-known firm trading for $3.

The company pays a big dividend too… 189% bigger than the S&P 500 average.

Get Your Free Report With The Oxford Club Subscription

Source: newsheater.com

Author: Irfan Tahir


Highlights from the Ratings and Financial Report for Evofem Biosciences Inc. (EVFM)

Highlights from the Ratings and Financial Report for Evofem Biosciences Inc. (EVFM)

Evofem Biosciences Inc. (NASDAQ:EVFM) went down by -4.24% from its latest closing price compared to the recent 1-year high of $7.50. The company’s stock price has collected 2.73% of gains in the last five trading sessions. Press Release reported on 11/20/20 that Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

Plus, the 36-month beta value for EVFM is at 0.32. Opinions of the stock are interesting as 2 analysts out of 4 who provided ratings for Evofem Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”

The average price from analysts is $7.00. EVFM currently public float of 79.95M and currently shorts hold a 9.31% ratio of that float. Today, the average trading volume of EVFM was 3.95M shares.

EVFM stocks went up by 2.73% for the week, with a monthly drop of -6.22% and a quarterly performance of -25.66%, while its annual performance rate touched -63.25%. The volatility ratio for the week stands at 5.07% while the volatility levels for the past 30 days are set at 6.54% for Evofem Biosciences Inc.. The simple moving average for the period of the last 20 days is -3.40% for EVFM stocks with a simple moving average of -39.34% for the last 200 days.

Many brokerage firms have already submitted their reports for EVFM stocks, with Stifel repeating the rating for EVFM by listing it as a “Buy.” The predicted price for EVFM in the upcoming period, according to Stifel is $5 based on the research report published on October 02nd of the current year 2020.

Morgan Stanley, on the other hand, stated in their research note that they expect to see EVFM reach a price target of $3. The rating they have provided for EVFM stocks is “Equal-Weight” according to the report published on August 20th, 2020.

A $3 Stock to Change Your Life: Find Out How

You can see why the world’s most famed tech companies are all signing blockbuster deals with this little-known firm trading for $3.

The company pays a big dividend too… 189% bigger than the S&P 500 average.

Get Your Free Report With The Oxford Club Subscription

Piper Sandler gave a rating of “Overweight” to EVFM, setting the target price at $11 in the report published on June 08th of the current year.

After a stumble in the market that brought EVFM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.87% of loss for the given period.

Volatility was left at 6.54%, however, over the last 30 days, the volatility rate increased by 5.07%, as shares sank -5.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.35% upper at present.

During the last 5 trading sessions, EVFM rose by +2.73%, which changed the moving average for the period of 200-days by -58.38% in comparison to the 20-day moving average, which settled at $2.33. In addition, Evofem Biosciences Inc. saw -63.37% in overturn over a single year, with a tendency to cut further losses.

Reports are indicating that there were more than several insider trading activities at EVFM starting from File Justin J., who purchase 7,760 shares at the price of $2.17 back on Nov 17. After this action, File Justin J. now owns 258,168 shares of Evofem Biosciences Inc., valued at $16,839 using the latest closing price.

Fitzpatrick Alexander A, the General Counsel and Secretary of Evofem Biosciences Inc., purchase 9,090 shares at $2.20 during a trade that took place back on Nov 17, which means that Fitzpatrick Alexander A is holding 143,542 shares at $19,998 based on the most recent closing price.

Equity return is now at value -365.00, with -157.10 for asset returns.

Based on Evofem Biosciences Inc. (EVFM), the company’s capital structure generated 1.26 points at debt to equity in total, while total debt to capital is 1.24.

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.09.

Source: newsheater.com

Author: Daisy Galbraith


How Property Booms Eat Our Economic Future

How Property Booms Eat Our Economic Future

how-property-booms-eat-our-economic-future

This October, U.S. housing sales hit their highest level since 2006. China’s residential real-estate investment was up 14% relative to the same month last year. Around the world, many housing markets have shrugged off a colossal economic slump, helped by low interest rates.

Source: www.financialnewsherald.com

Author: Written by FinancialNews

facebook

tumblr

twitter


Spanish Lenders BBVA, Sabadell Abandon Merger Talks


Leave a Comment